152 related articles for article (PubMed ID: 27876500)
1. Strong correlation between ASPM gene expression and HCV cirrhosis progression identified by co-expression analysis.
Wang F; Chang Y; Li J; Wang H; Zhou R; Qi J; Liu J; Zhao Q
Dig Liver Dis; 2017 Jan; 49(1):70-76. PubMed ID: 27876500
[TBL] [Abstract][Full Text] [Related]
2. Co-expression network analysis identified six hub genes in association with metastasis risk and prognosis in hepatocellular carcinoma.
Chen P; Wang F; Feng J; Zhou R; Chang Y; Liu J; Zhao Q
Oncotarget; 2017 Jul; 8(30):48948-48958. PubMed ID: 28430663
[TBL] [Abstract][Full Text] [Related]
3. Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis.
Cheng Y; Ping J; Chen J
Pathol Oncol Res; 2018 Jul; 24(3):507-514. PubMed ID: 28669080
[TBL] [Abstract][Full Text] [Related]
4. Diffusion of information throughout the host interactome reveals gene expression variations in network proximity to target proteins of hepatitis C virus.
Mosca E; Alfieri R; Milanesi L
PLoS One; 2014; 9(12):e113660. PubMed ID: 25461596
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of hepatocellular carcinoma and cirrhosis gene expression profiles.
Jiang M; Zeng Q; Dai S; Liang H; Dai F; Xie X; Lu K; Gao C
Mol Med Rep; 2017 Jan; 15(1):380-386. PubMed ID: 27959423
[TBL] [Abstract][Full Text] [Related]
6. A personalized approach identifies disturbed pathways and key genes in hepatitis C virus-cirrhosis with hepatocellular carcinoma.
Li YL; Zheng MX; Wang G
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4266-4273. PubMed ID: 27831648
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
[TBL] [Abstract][Full Text] [Related]
8. Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation.
Wang L; Huang J; Jiang M; Sun L
J Cell Biochem; 2011 May; 112(5):1286-94. PubMed ID: 21312234
[TBL] [Abstract][Full Text] [Related]
9. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
[TBL] [Abstract][Full Text] [Related]
10. The gene expression profiling of hepatocellular carcinoma by a network analysis approach shows a dominance of intrinsically disordered proteins (IDPs) between hub nodes.
Singh S; Colonna G; Di Bernardo G; Bergantino F; Cammarota M; Castello G; Costantini S
Mol Biosyst; 2015 Nov; 11(11):2933-45. PubMed ID: 26267014
[TBL] [Abstract][Full Text] [Related]
11. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma.
Mas VR; Maluf DG; Archer KJ; Yanek K; Kong X; Kulik L; Freise CE; Olthoff KM; Ghobrial RM; McIver P; Fisher R
Mol Med; 2009; 15(3-4):85-94. PubMed ID: 19098997
[TBL] [Abstract][Full Text] [Related]
12. From cirrhosis to hepatocellular carcinoma in HCV-infected patients: genes involved in tumor progression.
Wang Y; Li J; Chen J; Liu L; Peng Z; Ding J; Ding K
Eur Rev Med Pharmacol Sci; 2012 Aug; 16(8):995-1000. PubMed ID: 22913147
[TBL] [Abstract][Full Text] [Related]
13. Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis.
Li Y; Li J; He T; Song Y; Wu J; Wang B
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553600
[TBL] [Abstract][Full Text] [Related]
14. Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma.
Zheng S; Tansey WP; Hiebert SW; Zhao Z
BMC Med Genomics; 2011 Aug; 4():62. PubMed ID: 21824427
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis.
Huang XX; McCaughan GW; Shackel NA; Gorrell MD
Liver Int; 2007 Sep; 27(7):960-8. PubMed ID: 17696935
[TBL] [Abstract][Full Text] [Related]
16. Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection.
Whitmill A; Kim S; Rojas V; Gulraiz F; Afreen K; Jain M; Singh M; Park IW
PLoS One; 2018; 13(8):e0202524. PubMed ID: 30138348
[TBL] [Abstract][Full Text] [Related]
17. Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patients.
Shao RX; Hoshida Y; Otsuka M; Kato N; Tateishi R; Teratani T; Shiina S; Taniguchi H; Moriyama M; Kawabe T; Omata M
World J Gastroenterol; 2005 Apr; 11(13):1995-9. PubMed ID: 15800993
[TBL] [Abstract][Full Text] [Related]
18. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
Zekri AR; Moharram RA; Mohamed WS; Bahnassy AA; Alam El-Din HM; Abo-Shadi MM; Zayed NA; El-Magzangy H; Abdel-Aziz AO; Esmat G
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):450-6. PubMed ID: 19858727
[TBL] [Abstract][Full Text] [Related]
19. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
[TBL] [Abstract][Full Text] [Related]
20. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]